Dural Ectasia in Neurofibromatosis 1: Case Series, Management, and Review.


Journal

Neurosurgery
ISSN: 1524-4040
Titre abrégé: Neurosurgery
Pays: United States
ID NLM: 7802914

Informations de publication

Date de publication:
01 05 2020
Historique:
accepted: 06 04 2019
received: 18 07 2018
pubmed: 28 7 2019
medline: 20 11 2020
entrez: 28 7 2019
Statut: ppublish

Résumé

The natural history and management of dural ectasia in Neurofibromatosis 1 (NF1) is still largely unknown. Dural ectasias are one of the common clinical manifestations of NF1; however, the treatment options for dural ectasias remain unstudied. To investigate the natural history, diagnosis, management, and outcome of the largest case series of patients with NF1-associated dural ectasia to date. Records from our NF1 clinic were reviewed to identify NF1 patients with computed tomography or magnetic resonance imaging evidence of dural ectasia(s) to determine their clinical course. Demographics, symptoms, radiographic and histopathologic findings, treatment, and clinical course were assessed. Thirty-four of 37 patients were managed without surgery. Of the 18 initially asymptomatic patients, 5 (27.8%) progressed to symptoms attributable to a dural ectasia (onset of 2.7% per patient-year). Three patients required surgical intervention because of extraspinal mass effect. All 3 initially improved but had symptom recurrence within 2 yr. Reoperation involved shunt placement for cerebrospinal fluid (CSF) diversion. On imaging review, 26 (76.5%) of the nonsurgical patients harbored an associated nearby plexiform neurofibroma. Pathology of one surgical case revealed dural infiltration by diffuse neurofibroma. Using the largest NF1-associated dural ectasia group to date, we report the first symptom-onset rate for nonsurgical patients. In the few cases requiring surgery for decompression, primary resection, and patching of ectasias failed, subsequently requiring CSF shunting. We demonstrate imaging evidence of nearby plexiform neurofibroma in a majority of cases, which, when combined with histopathology, provides a novel explanation for the formation of dural ectasias.

Sections du résumé

BACKGROUND
The natural history and management of dural ectasia in Neurofibromatosis 1 (NF1) is still largely unknown. Dural ectasias are one of the common clinical manifestations of NF1; however, the treatment options for dural ectasias remain unstudied.
OBJECTIVE
To investigate the natural history, diagnosis, management, and outcome of the largest case series of patients with NF1-associated dural ectasia to date.
METHODS
Records from our NF1 clinic were reviewed to identify NF1 patients with computed tomography or magnetic resonance imaging evidence of dural ectasia(s) to determine their clinical course. Demographics, symptoms, radiographic and histopathologic findings, treatment, and clinical course were assessed.
RESULTS
Thirty-four of 37 patients were managed without surgery. Of the 18 initially asymptomatic patients, 5 (27.8%) progressed to symptoms attributable to a dural ectasia (onset of 2.7% per patient-year). Three patients required surgical intervention because of extraspinal mass effect. All 3 initially improved but had symptom recurrence within 2 yr. Reoperation involved shunt placement for cerebrospinal fluid (CSF) diversion. On imaging review, 26 (76.5%) of the nonsurgical patients harbored an associated nearby plexiform neurofibroma. Pathology of one surgical case revealed dural infiltration by diffuse neurofibroma.
CONCLUSION
Using the largest NF1-associated dural ectasia group to date, we report the first symptom-onset rate for nonsurgical patients. In the few cases requiring surgery for decompression, primary resection, and patching of ectasias failed, subsequently requiring CSF shunting. We demonstrate imaging evidence of nearby plexiform neurofibroma in a majority of cases, which, when combined with histopathology, provides a novel explanation for the formation of dural ectasias.

Identifiants

pubmed: 31350851
pii: 5539786
doi: 10.1093/neuros/nyz244
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

646-655

Informations de copyright

Copyright © 2019 by the Congress of Neurological Surgeons.

Auteurs

Sean P Polster (SP)

Section of Neurosurgery, Department of Surgery, University of Chicago Medicine, Chicago, Illinois.

Mark C Dougherty (MC)

Section of Neurosurgery, Department of Surgery, University of Chicago Medicine, Chicago, Illinois.

Hussein A Zeineddine (HA)

Section of Neurosurgery, Department of Surgery, University of Chicago Medicine, Chicago, Illinois.

Seán B Lyne (SB)

Section of Neurosurgery, Department of Surgery, University of Chicago Medicine, Chicago, Illinois.

Heather L Smith (HL)

Section of Neurosurgery, Department of Surgery, University of Chicago Medicine, Chicago, Illinois.

Cynthia MacKenzie (C)

Ambulatory Program for Neurofibromatosis, Department of Pediatrics and Neurology, University of Chicago Medicine, Chicago, Illinois.

Peter Pytel (P)

Department of Pathology, University of Chicago Medicine, Chicago, Illinois.

Carina W Yang (CW)

Department of Radiology, University of Chicago Medicine, Chicago, Illinois.

James H Tonsgard (JH)

Ambulatory Program for Neurofibromatosis, Department of Pediatrics and Neurology, University of Chicago Medicine, Chicago, Illinois.

Peter C Warnke (PC)

Section of Neurosurgery, Department of Surgery, University of Chicago Medicine, Chicago, Illinois.

David M Frim (DM)

Section of Neurosurgery, Department of Surgery, University of Chicago Medicine, Chicago, Illinois.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH